Kanou Seiya, Nakatani Eiji, Urano Tetsumei, Sasaki Hatoko, Inoue Akihiko, Hifumi Toru, Sakamoto Tetsuya, Kuroda Yasuhiro, Tanaka Yoshihiro
Graduate School of Public Health, Shizuoka Graduate University of Public Health, Shizuoka, Japan.
Department of Emergency and Critical Care Center, Fujieda Municipal General Hospital, Fujieda, Japan.
Res Pract Thromb Haemost. 2025 Feb 7;9(2):102700. doi: 10.1016/j.rpth.2025.102700. eCollection 2025 Feb.
•Hypofibrinogenemia frequently occurs in extracorporeal cardiopulmonary resuscitation (ECPR) and may heighten bleeding risk. This subanalysis of a multicenter observational study (SAVE-J II) included 2,100 adult patients receiving ECPR after out-of-hospital cardiac arrest at 36 facilities in Japan.•Overall, 7.5% of patients experienced non-cannulation hemorrhagic complications, and those with fibrinogen levels below 140 mg/dL at ECPR initiation faced significantly higher bleeding risk. These findings underscore the importance of monitoring and managing fibrinogen levels in ECPR to mitigate hemorrhagic events and improve patient outcomes.
•低纤维蛋白原血症在体外心肺复苏(ECPR)中经常发生,可能会增加出血风险。这项对一项多中心观察性研究(SAVE-J II)的亚分析纳入了日本36家机构中2100例院外心脏骤停后接受ECPR的成年患者。•总体而言,7.5%的患者发生了非插管出血并发症,在开始ECPR时纤维蛋白原水平低于140mg/dL的患者面临的出血风险显著更高。这些发现强调了在ECPR中监测和管理纤维蛋白原水平以减轻出血事件和改善患者预后的重要性。